The voltage-gated sodium channel NaV1.7, encoded by the gene SCN9A, is located in peripheral neurons and plays an important role in epileptogenesis. Previous studies have identified an increasing number of SCN9A mutations in patients with variable epilepsy phenotypes. Phenotypes of SCN9A mutations include febrile seizures (FS), genetic epilepsy with febrile seizures plus (GEFS+), and Dravet syndrome (DS), which pose challenges in clinical treatment. Here, we identified a heterozygous SCN9A mutation (c.980G > A chr2:167149868 p.G327E) from two twin sisters with Rolandic epilepsy by whole-exome sequencing. The patient became seizure free with a combination of levetiracetam and clonazepam. Identification of this mutation is also helpful for advancing our understanding of the role of SCN9A in epilepsy and provides deeper insights for SCN9A mutations associated with broad clinical spectrum of seizures.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10072-019-03752-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Paroxysmal extreme pain disorder associated with a mutation in SCN9A gene - Case report and own experiences.
Front Neurol
December 2024
Department of Surgery, Institute of Medical Sciences, Medical College of Rzeszów University, Rzeszów, Poland.
Introduction: Pain is an unpleasant sensory and emotional experience, influenced by various factors. Paroxysmal extreme pain disorder (PEPD) is a rare genetic condition characterized by sudden bouts of pain accompanied by autonomic symptoms.
Material Methods And Aim: This manuscript presents the case of a 9-year-old boy with paroxysmal extreme pain syndrome and provides a review of the literature.
Molecular genetics in adult-onset Still's disease: next-generation sequencing in 24 patients and literature review.
Front Immunol
November 2024
Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Objective: Next-generation sequencing (NGS) panels are increasingly used for the diagnosis of monogenic systemic autoinflammatory diseases (SAIDs). However, their role in patients with adult-onset Still's disease (AOSD) remains unknown. This study aims to assess the usefulness of NGS panels in AOSD patients to improve diagnosis and management of the disease.
View Article and Find Full Text PDF[Genetic analysis of a child with Congenital insensitivity to pain due to compound heterozygous variants of SCN9A gene].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
November 2024
Department of Medical Genetics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Objective: To explore the genetic etiology of a child featuring multiple fractures and congenital insensitivity to pain (CIP).
Methods: A child who had presented at the West China Hospital of Sichuan University on March 16, 2023 for recurrent fractures and CIP was selected as the study subject. Peripheral blood samples of the child and his parents was collected.
Previously defined variants of uncertain significance may play an important role in epilepsy and interactions between certain variants may become pathogenic.
Epilepsia Open
December 2024
Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Objective: Epilepsy is a chronic neurological disorder related to various etiologies, and the prevalence of active epilepsy is estimated to be between 4 and 10 per 1000 individuals having a significant role in genetic mutations. Next-Generation Sequencing (NGS) panels are utilized for genetic testing, but a substantial proportion of the results remain uncertain and are not considered directly causative of epilepsy. This study aimed to reevaluate pediatric patients diagnosed with epilepsy who underwent genetic investigation using NGS panels, focusing on inconclusive variant findings or multiple variants of uncertain significance (VUSs).
View Article and Find Full Text PDFCongenital Insensitivity to Pain: A Case Study of a Rare Genetic Disorder.
Cureus
September 2024
Surgery, School of Medicine, Al-Quds University, Jerusalem, PSE.
Article Synopsis
- - Congenital insensitivity to pain (CIP) is a rare genetic condition caused by mutations in the Nav1.7 gene, leading to a loss of pain sensation.
- - A specific case describes a patient with a homozygous mutation that causes a premature stop in protein production, which is classified as "probable pathogenic" by medical guidelines.
- - Early detection and proper medical care can help manage symptoms and improve life expectancy for individuals with CIP, who often show signs from birth or infancy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!